INNOVIVA
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 11 Apr 2025)
What this means for you
Registered since 18 Jun 2019. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 86828724
- Registration number
- 5781951
- Mark type
- Stylized text
- Filed
- 23 Nov 2015
- Published for opposition
- 13 Dec 2016
- Registered
- 18 Jun 2019
- Attorney of record
- Caitlin R. Byczko
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals, namely, pharmaceutical preparations for the treatment of respiratory diseases and disorders; Pharmaceuticals, namely, pharmaceutical products for treating respiratory diseases; Pharmaceuticals, namely, pharmaceutical preparations for the treatment of asthma and chronic obstructive pulmonary disease; Pharmaceuticals, namely, pharmaceutical products for treating asthma
Owner
- Innoviva, Inc., Burlingame, CA, US
- Theravance, Inc., Brisbane, CA, US
- Theravance, Inc., Brisbane, CA, US
- Theravance, Inc., South San Francisco, CA, US
Prosecution history
- 11 Apr 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 11 Apr 2025 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 11 Apr 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 30 Dec 2024 — TEAS SECTION 8 & 15 RECEIVED
- 18 Jun 2024 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 18 Jun 2019 — REGISTERED-PRINCIPAL REGISTER
- 17 May 2019 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 16 May 2019 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 15 May 2019 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 14 May 2019 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 14 May 2019 — TEAS REQUEST FOR RECONSIDERATION RECEIVED
- 14 Mar 2019 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 14 Mar 2019 — FINAL REFUSAL E-MAILED
- 14 Mar 2019 — SU - FINAL REFUSAL - WRITTEN
- 13 Mar 2019 — TEAS/EMAIL CORRESPONDENCE ENTERED